PG-012

N/A

Report date: 2026/05/14 20:00:28

Base Information

Drug NamePG-012
Drug Alias NamePG012
ClassificationBiologics > NK cell engagers
Mechanisms of ActionFCGR3A (CD16a) NK-cell engagers
TargetsLow affinity immunoglobulin gamma Fc region receptor III-A
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPersongen Biotherapeutics (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPersongen Biotherapeutics (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A